Articles tagged with Cost Effectiveness
A cost-effectiveness study found that six out of eight newborn screening tests were not only cost-effective but also cost-saving. The tests identified rare disorders such as hypothyroidism and phenylketonuria, which can have significant impacts on children's health and development.
The BCG vaccine is highly cost-effective in preventing severe childhood tuberculosis, with an estimated cost of US$200 per year of healthy life gained. The largest impact was found in southeast Asia, Africa, and the western Pacific region, where TB infection rates and BCG coverage are highest.
A new study of 50,000 people found that heavy smoking leads to a higher risk of premature death, particularly among men and women. The study also highlighted the benefits of quitting smoking early, with those who quit experiencing greater health benefits and longevity.
Researchers suggest using a microvolt T-wave alternans (MTWA) test to help determine which patients need implanted defibrillators, reducing costs for Medicare. The study estimates that this approach could save $690 million annually.
A study analyzing healthcare utilization data for HIV-infected patients found that HAART is cost-effective as long as patients stick to treatment. However, the study also revealed significant disparities in healthcare costs between healthier and sicker patients, highlighting inadequate reimbursement to treating physicians and clinics.
Researchers found HPV DNA testing to be a cost-effective strategy for women with ASCUS, detecting more precancer cases than immediate colposcopy. The approach was also less costly, making it economically viable.
Researchers developed a new approach to analyze drug effectiveness data, providing insights into the cost-effectiveness of newer and older anti-epileptic drugs. The study suggests that two older drugs, valproate and carbamazepine, are likely to be more cost-effective for newly diagnosed patients with partial seizures.
Researchers found that newborn screening for SCID could be cost-effective due to the benefits of early diagnosis and the potential to save lives. A two-tiered strategy combining existing tests has been shown to improve accuracy without increasing costs, making it a promising approach for nationwide screening programs.
A team care model, including a case manager and primary care provider, results in better outcomes for treating clinical depression. The IMPACT program provides powerful health benefits, including decreased depression and pain, improved physical functioning, and better overall quality of life.
A new study found that drug-eluting stents like CYPHER are cheaper than open-heart surgery, saving patients and the healthcare system $6,487 on average over a year. The research also shows improved patient outcomes with stent treatment.
Researchers found that ICDs provide value in appropriate patients, but more research is needed to identify high-risk patients who would benefit most from the therapy. The study suggests that ICD use could be more cost-effective with lower implantation costs or extended device lifespan.
The BASKET trial compares the costs and outcomes of drug-eluting stents (DES) and bare-metal stents (BMS) in 826 patients with PCI. The study aims to identify patient subgroups where DES are cost-effective, potentially impacting daily practice and preferences.
Since the introduction of the varicella vaccine, hospitalizations due to chicken pox have decreased by 88% and ambulatory visits by 59%, according to a recent study. These declines are observed across all age groups, with infants under 1 year experiencing the most significant reductions in hospitalizations.
The National Institute of Standards and Technology (NIST) has released a draft federal IT security standard, FIPS Publication 200, to aid in FISMA compliance. The document provides guidelines for minimum security requirements and a risk-based approach for selecting security controls.
A study examines the cost-effectiveness of HPV testing in France, Italy, the Netherlands, and the UK, finding both triage and combination strategies to be more effective than current cytology-based screening programs. The cost-effectiveness ratios range from $9,800 to $75,900 per year of life saved, depending on the screening interval.
The study found that the newest drug therapy – adefovir – was not cost-effective when taken alone but became very cost-effective when reserved as a second-line agent in people who develop viral resistance for lamivudine. The hybrid treatment strategy of lamivudine and adefovir is also a viable option.
A new study finds that statin therapy can significantly reduce hospitalization costs and costs of major vascular events. The cost-effectiveness of treatment varies depending on individual risk levels, with lower-risk groups potentially benefiting from statins.
A new study assesses the cost-effectiveness of pharmaceuticals in different countries, highlighting the importance of considering location-specific factors. The findings emphasize that economic evaluations are not transferable across borders, requiring repeated studies to determine cost-effectiveness.
Two studies examine the prevention of type 2 diabetes mellitus, a condition that affects millions of Americans. Researchers found positive lifestyle changes lowered risk among nonsmokers but not smokers. A computer simulation determined the diet-exercise program and metformin therapy were cost-effective options.
The BIOS Initiative provides a new licensing mechanism that encourages sharing of core tools of innovation, empowering researchers worldwide. The launch of BioForge, an online collaborative research platform, enables scientists to work together to craft new technologies within a protected commons.
A new study recommends expanding routine HIV screening to settings with low prevalence rates due to its cost-effectiveness. The study found that even at low prevalence levels, regular testing can provide important health benefits. Additionally, the researchers suggest that screenings should be expanded to reduce the transmission of the...
A new stroke-prevention drug, Exanta, has been shown to reduce the risk of major hemorrhage by 26% and is equivalent to warfarin in preventing strokes. However, its high price makes it cost-ineffective for most patients at low risk of bleeding, except those with a high risk of both stroke and bleeding.
This article discusses the association between non-hazardous alcohol consumption and injury, as well as barriers to treating depression among young adults. Studies find that excessive drinking causes significant injuries, while negative attitudes towards treatment may prevent youth from accepting diagnosis and care.
The study highlights the need for improved decision-analytic models to capture the complexity of PD symptoms and treatment complications. Long-term effects of treatment on clinical symptoms and health-related quality of life are crucial in evaluating PD interventions.
A Fox Chase Cancer Center study found IMRT to be cost-effective for men with intermediate-risk prostate cancer, improving quality-adjusted survival and reducing the need for additional treatments. The study's findings suggest that IMRT may offer better value compared to traditional conformal radiotherapy.
A meta-analytic review found that home visiting programs enhance parenting behaviors, increase educational attainment, and boost children's cognitive and social skills. While the benefits are statistically significant, the magnitude of the impact varies.
A study of 56,000 people from Wichita, Kansas found that Chronic Fatigue Syndrome causes a significant burden on the economy, with lost productivity estimated at $9.1 billion annually. The syndrome affects approximately 450,000 individuals nationwide, resulting in substantial economic losses and reduced household income.
Researchers found that over half of COX-2 patients take aspirin, leading to a loss of GI protective effects and increased risk of bleeding. Patients should consider alternative NSAIDs or proton pump inhibitors for added protection.
Researchers at Express Scripts found that COX-2 prescribing physicians often co-prescribe gastroprotective drugs, contradicting expert estimates. This challenges the use of expert opinion in estimating practice pattern model inputs and warrants re-evaluation of COX-2 cost-effectiveness models.
The NIH consensus panel confirms the effectiveness of total knee replacement surgery, highlighting the importance of surgeon volume and proper prosthesis alignment to minimize long-term complications. Computer navigation technology may eventually reduce malalignment risks but is currently unproven and costly.
The use of clopidogrel in addition to aspirin significantly reduces the risk of recurrent heart attacks, strokes, or cardiovascular death. The cost-effectiveness analysis suggests that at least one year of therapy with clopidogrel is an attractive value for patients at risk.
The new yellow bus features alternative fuel, a low floor, and complies with the Americans with Disabilities Act (ADA), providing easy accessibility for passengers. The bus is designed to reduce dependence on foreign energy sources and protect national parks' pristine environment.
A new study by the American College of Physicians found that treating older adults with flu-like symptoms can be cost-effective, but preventing them through annual vaccinations is more beneficial. Vaccination decreases hospitalization needs and mortality rates, making it the best strategy for older adults.
A study found that only 10% of sore throat cases are caused by bacteria, making antibiotic treatment without diagnosis ineffective. The traditional culture method was the most effective and least expensive way to diagnose strep throat, despite its limitations.
A novel method integrates habitat modelling and spatial population dynamics in reserve-network design to consider the impact of habitat loss on species survival. This approach represents a step towards more realistic consideration of species survival when selecting reserve networks.
A new study suggests that pneumococcal vaccination can save medical costs for individuals aged 50 to 64, particularly those at high risk of pneumococcal disease. The cost-effectiveness of vaccination is comparable to other preventive services in this age group.
A new study suggests that lung-volume-reduction surgery may be a cost-effective treatment for severe emphysema, particularly for patients who respond well to the procedure. The surgery costs around $35,000 per person, but its long-term cost-effectiveness is uncertain due to limited follow-up data.
The Stanford study found that FDG-PET is highly effective for lung nodule diagnosis but most cost-effective when used selectively with CT scans. The researchers recommend relying on CT as the initial test for almost all patients and using FDG-PET in cases where the risk of cancer conflicts with CT results.
A global study identifies cost-effective strategies to reduce the burden of cardiovascular disease, prioritizing non-personal interventions such as salt reduction and health education. Combination treatments with blood pressure and cholesterol-lowering agents are also shown to be effective in reducing disease impact worldwide.
A new study highlights the cost-effectiveness of reducing sodium in processed foods to limit cardiovascular disease, while also recommending a combination of treatments for high-risk individuals. The research found that targeting blood pressure and cholesterol levels could prevent over 21 million DALYs per year worldwide.
A recent study found drotrecogin alfa (activated) to be as cost-effective as several commonly used life-saving treatments, including statins and lung transplants. The drug's acquisition cost falls below the $100,000 per QALY threshold for cost-effectiveness.
A recent study found that annual whole-body CT scanning for lung cancer screening may not be effective in saving lives, as the costs outweigh the benefits. The researchers estimated that only smokers who started quitting at age 55-65 saw significant cost-effectiveness in screening.
A study compared the impact of young adult teams (YAT) and ad hoc services on young disabled people's participation in society. YATs were found to be more effective, with participants being 2.5 times more likely to engage in activities. The findings suggest that coordinated multidisciplinary teams can make a difference at no extra cost.
The Disease Control Priorities Project (DCPP) will analyze cost-effectiveness of health interventions, providing data for policymakers to make informed decisions. The project aims to develop highly effective, affordable health solutions that can be emulated globally.
A recent study estimates that cigarette tax hikes could prevent between 5 million to 16 million tobacco-related deaths globally. The greatest savings would be in low- and middle-income countries, with the greatest impact on young smokers. Price increases are considered the most cost-effective anti-smoking intervention.
A USC study found that preventive occupational therapy significantly improves quality of life and reduces medical costs for seniors. The study involved three groups of culturally diverse adults over 60, with the intervention group showing marked improvements in physical and emotional well-being without increasing healthcare costs.
A study assessing existing data on HIV/AIDS interventions found that cost-effectiveness varies greatly between interventions. Some interventions, such as selective blood safety measures and targeted condom distribution, can prevent a case of HIV/AIDS for under $11 and gain over $1 in disability-adjusted life-years (DALYs) per dollar spent
Researchers found that immunizing 50-75% of Americans aged 1-30 could save hundreds of lives compared to ring vaccination alone. The study suggests mass vaccination campaigns targeting young people may be cost-effective in preventing deaths from a potential smallpox attack.
A study in Annals of Internal Medicine finds that accurate profiling of physician care depends on study design, and that most quality initiatives fail to adjust for patient characteristics. Additionally, researchers estimate that colonoscopy is a cost-effective strategy for investigating rectal bleeding in young people
The USF report ranks 66 Florida counties based on overall health ratings, with top-scoring counties having better healthcare and lower poverty rates. The report also highlights deficiencies in high-performing counties, such as lack of health screening and primary care measures.
A new Stanford University study analyzed the costs and benefits of two treatments: implantable cardioverter defibrillators (ICDs) and the drug amiodarone. ICDs were found to be the most effective in preventing sudden cardiac death, but also came with the highest costs. Amiodarone produced intermediate benefits and costs.
A study of 2,437 HIV-infected adults found that patients with case managers had fewer unmet needs and higher use of HIV medications. Screening for hereditary colorectal cancer has been shown to work and may be cost-effective, particularly for relatives of affected individuals.
Dougherty and DeBord developed a new process for producing di-t-octylhydroquinone (DOH) using two catalysts, resulting in good quality yields over short reaction times. The process also reduces the need for solvents, which can be recovered and recycled.
Dr. Linda M. Hanagan's innovative approach uses active control systems to dampen vibrations in existing buildings, reducing costs and time required compared to traditional stiffening or thickening methods. The system can be applied quickly, often taking less than a week to fix the problem.
A leading economist argues that the UK's National Health Service (NHS) is in 'political denial' about the need for rationing due to inefficient practices and a lack of evidence-based policies. The expert suggests targeting cost-effective activities to maximize health improvements using limited resources.
A mathematical model suggests that one-time colonoscopy at age 55 can significantly reduce colorectal cancer mortality. The study found that this strategy is cost-effective and can achieve up to 50% reduction in CRC mortality, depending on compliance.
Researchers at Johns Hopkins Medicine found that cochlear implants improve quality of life and save $50,000+ over a child's lifetime. The study provides evidence that pediatric cochlear implantation is highly cost-effective from a societal perspective.
Expansion of methadone programs would reduce the spread of HIV to the general population, resulting in significant health benefits. The study estimated that expansion of methadone treatment capacity would cost between $8,200 and $10,900 for every quality-adjusted life year gained.
Two studies in Annals of Internal Medicine explore cost-effectiveness of statins on specific populations. Statin therapy was found to be reasonably cost-effective for patients aged 75-84 years old with a history of heart attack, increasing life expectancy by four months while costing $18,800 per quality-adjusted life year. Cost-effecti...
Recent studies analyzed the cost-effectiveness of various heart failure treatments, including ACE inhibitors, vasodilators, and interdisciplinary teams. The findings suggest that judicious use of these therapies can lead to significant cost savings while maintaining effective treatment outcomes.